Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (26)	1/19/1998 3:58:00 PM
From: Instock	Respond to of 29382

Sergio: Yes, read it last night. Good article! When the Markets calm down some, it will be safer being an investor. With the volitility the markets have been having recently, I for one, feel safer getting in and getting out. I think many have been burned in the past few months and are either thinking like myself or just not playing stocks at all. There are still MANY good investments out there, short, med. and long term. In the near future, I plan to start looking a bit longer term then current 5 days or less. Good look. I will be here, reading the thread, and keeping up as best as time allows. Scott

To: Sergio H who wrote (26)	1/19/1998 4:48:00 PM
From: Amigo Mike	Read Replies (2) \| Respond to of 29382

Hi Amigos, Been looking close at DSCO. It appears to be very intriguing indeed. Discovery Laboratories, Inc. is a New York City based development stage pharmaceutical company that is clinically developing proprietary pharmaceuticals to treat post-menopausal osteoporosis, adult respiratory distress syndrome (ARDS), meconium aspiration syndrome (MAS) and cystic fibrosis (CF). Discovery's strategy is to accelerate and lower the risk of drug development by acquiring and developing proprietary pharmaceuticals for which significant animal or human testing has already been completed. In addition, Discovery seeks to minimize the cost of drug development by outsourcing preclinical development and manufacturing. Hospital based pharmaceuticals are developed at Discovery's majority-owned privately held subsidiary, Acute Therapeutics, Inc., located in Doylestown, Penn. More information about Discovery is available on the company's web site at: discoverylabs.com This company has a very small float yet the trading activity during the last week+ has been relatively high based on previous activity. Hmmmmmm ..... my GUT tells me something is happening here .... may have fly by the seat of my pants Tuesday morning on this one. Hmmm ... maybe a week or two trade on this one. I think there are some insider purchases recently also. Mike